Log In
Sign Up
Cetuximab
Indications
It is used with other relevant treatments in advanced squamous cell carcinoma of the head and neck, recurrent locoregional disease or metastatic squamous cell carcinoma of the head and neck, and recurrent or metastatic squamous cell carcinoma of the head, neck progressing after platinum-based therapy, and in colorectal cancer.
Dose/Application
400 mg/m2 initially (infused over a period of 2 hrs) then 250 mg/m2 weekly. To administer an H1 receptor antagonist prior to initiation of treatment.
Mode of action
Precautions
Contraindications
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Erbitux injection 5 mg / mL; 20 mL 1 KES24,223.00
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us